Gonococci possessing certain opacity-associated (Opa) outer membrane proteins adhere to and are phagocytosed by human neutrophils in the absence of serum. Recently, it has been shown that serum-sensitive strains of Neisseria gonorrhoeae possessing the appropriate lipooligosaccharide phenotype become serum resistant when grown in the presence of CMP-N-acetylneuraminic acid (CMP-NANA) because of sialylation of their lipooligosaccharide. We investigated whether such sialylation affects nonopsonic (antibody-and complement-independent) interactions of gonococci with human neutrophils in vitro. We grew Opa+ gonococci in the presence of up to 50 ,ug of CMP-NANA per ml, incubated them with neutrophils in vitro, and measured their abilities to adhere to neutrophils, stimulate neutrophil luminol-dependent chemiluminescence (LDCL), and be phagocytically killed by neutrophils. Growth in CMP-NANA dramatically inhibited (in a dose-dependent manner) the ability of Opa+ gonococci to adhere to neutrophils and stimulate neutrophil LDCL. Growth of Opa+ gonococci in 50 jg of CMP-NANA per ml appeared to delay, but did not inhibit, their killing by neutrophils. Sialidase treatment of sialylated Opa+ gonococci, i.e., gonococci grown with CMP-NANA, totally restored their abilities to adhere to neutrophils and stimulate neutrophil LDCL. Opa-gonococci grown in the presence of 50 ,ug of CMP-NANA per ml and opsonized with fresh human serum bound to neutrophils only about 30% less efficiently than did Opa-gonococci grown without CMP-NANA and opsonized. The results of our studies show that sialylated Opa+ gonococci have dramatically reduced nonopsonic interactions with neutrophils. Some gonococcal strains may resist killing by human neutrophils in vivo by such a mechanism.
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Gonorrhea is characterized by a cervical or urethral purulent exudate comprising tremendous numbers of neutrophils and free and cell-associated Neisseria gonorrhoeae organisms (4, 10, 16, 35, 36, 61, 62) . Gonococci can interact with human neutrophils by nonopsonic (antibody-and complement-independent) mechanisms if they possess one or more of a family of heat-modifiable outer membrane proteins termed opacity-associated (Opa) proteins (previously called PII proteins) (13, 17, 23-26, 45, 47, 50, 51, 52, 55, 59, 60, 64) . Opa proteins are one of several gonococcal outer membrane components that undergo frequent antigenic and/or phase variation (8, 15, 32, 49 ). An individual gonococcus can possess about a dozen Opa genes and can express zero to three or more Opa proteins at a time (2, 3, 7, 8, 15) . Most Opa+ gonococci are phagocytized and killed by human neutrophils and induce a neutrophil oxidative burst (13, 47, 59) .
Most studies of the interactions of gonococci with human neutrophils have been performed in vitro, with gonococci grown in vitro, by using isolated peripheral blood neutrophils. A few studies, however, most notably, a series of investigations by Harry Smith and Nicholas Parsons and their colleagues, investigated the interactions of human neutrophils and gonococci by studying urethral exudates from males with gonorrhea (5, 6, 39-42, 57, 61, 65) . The studies suggest that a substantial percentage of in vivogrown gonococci remain viable after prolonged exposure to exudate neutrophils. Such results are in stark contrast to results of the in vitro studies cited above, in which gonococci * Corresponding author.
were killed readily by neutrophils over a relatively short period, generally <3 h (13, 47, 59) . Thus, gonococci grown in vivo appear to be different from gonococci grown in vitro in regard to their interaction with human neutrophils.
Yet another elegant and detailed set of experiments by Harry Smith and Nicholas Parsons and their coworkers and collaborators culminated in an exciting and unique set of observations (reviewed by Smith [48] ). Whereas most strains of gonococci taken directly from urethral exudates are resistant to serum killing, the same gonococci passaged at least once on laboratory medium become serum sensitive (63) . Conversely, serum-sensitive gonococci grown in vitro in the presence of human serum, genital secretions or erythrocytes, or their extracts, become serum resistant (29-31, 43, 44, 54, 58) . This serum resistance is due to covalent transfer of sialic acid (N-acetylneuraminic acid [NANA] ) by a sialyltransferase from CMP-NANA to gonococcal lipooligosaccharide (LOS) (28, 34, 37, 43) . Such sialylation apparently prevents binding of bactericidal anti-LOS antibody to the gonococcus (37, 38) . Thus, most strains of gonococci grown in vitro interact with human serum differently than do gonococci grown in vivo.
Apicella et al. have recently shown that gonococci associated with neutrophils in urethral exudates from males with gonorrhea are sialylated, indicating that sialylation indeed occurs in vivo (1, 28) . Thus, gonococci grown in vivo interact with serum or neutrophils differently than do gonococci grown in vitro. In the studies presented below, we determined that sialylation of gonococcal LOS in vitro, by growth in the presence of CMP-NANA, altered the nonopsonic, i.e., Opa-mediated, association of Opa+ gonococci with human peripheral blood neutrophils in vitro. equal to 2 x 10 to 4 x 10 gonococci per ml) and kept at room temperature or 37°C until used or (ii) suspended in 5 or 10 ml of warm GC broth plus added supplements, grown for about 3 h to mid-log phase, washed once in PBSG, and suspended as described above, as previously described (46 (27) . SDS-PAGE gels were silver stained as described by Tsai and Frasch (56 grown in the presence of CMP-NANA expressed an altered LOS phenotype, as shown by subjecting proteinase Ktreated whole gonococci to SDS-PAGE and subsequently identifying LOS bands by silver staining (Fig. 3) . The faster migrating of the two LOS bands of our nonsialylated strain F62 showed decreased mobility, reflecting its increased molecular weight, presumably because of addition of at least one sialic acid (309 daltons) to a terminal LOS galactose (Fig. 3 , compare lanes C and D) (28) .
(ii) We Opa+ gonococci that were grown in the presence of 50 pLg of CMP-NANA per ml and then treated with increasing concentrations of sialidase. If gonococci grown in the presence of CMP-NANA adhered less well to neutrophils because they were sialylated, then sialidase should remove sialic acid and restore (increase) their adherence to the level of adherence seen for control gonococci grown in the absence of CMP-NANA. Indeed, sialidase treatment completely restored the ability of Opa+ gonococci grown in the presence of CMP-NANA to adhere to neutrophils (Fig. 4) . The effects of sialidase were very obvious upon viewing of Wrightstained smears of adherence assays performed with gonococci grown in CMP-NANA and treated without or with 0.05 U of sialidase per ml (compare Fig. 2B and D Fig. 2C and D) . This indicated that sialidase treatment had minimal nonspecific effects on adherence of nonsialylated (control) Opa4 gonococci to neutrophils. LOS profiles of gonococci grown in CMP-NANA and treated with sialidase matched those of the nonsialylated (control) LOS phenotype (Fig. 3, compare  lanes B and D) . Treatment of control gonococci (grown in the absence of CMP-NANA) with sialidase did not alter the apparent mobility of nonsialylated LOS as observed by SDS-PAGE (Fig. 3, compare lanes A and D) .
Growth of Opa4 gonococci in the presence of CMP-NANA The same controls used for the adherence studies were used for the LDCL studies. Thus, after growth in 50 ,ug of CMP-NANA per ml, strain F62 showed an altered LOS phenotype, whereas F62E (the nonsialylatable variant) stimulated LDCL to the same extent as did F62Y; grown in the absence of CMP-NANA (data not shown). In addition, sialidase, in a dose-dependent manner, restored the ability of sialylated Opa4 gonococci to induce LDCL (Fig. 5) . Sialidase at the highest concentration used in these assays (0.066 U/ml) did not induce neutrophil LDCL in the absence of gonococci (Fig. 5, open triangles) .
High concentrations of sialidase did have some additional effect on the ability of gonococci to induce LDCL, since gonococci treated with the highest concentration of sialidase (0.066 U/ml) (Fig. 5, closed triangles) induced more LDCL than did control (untreated) gonococci (Fig. 5, open circles) . This effect remains uninvestigated.
Phagocytic killing of gonococci grown in the presence of CMP-NANA. Gonococci possessing most Opa proteins are phagocytically killed by human neutrophils in the absence of serum (47) . To determine whether sialylation of gonococci can affect this activity, phagocytic-killing assays were performed with Opa4 gonococci grown in the presence or absence of 50 ,ug of CMP-NANA per ml. Slightly variant results were obtained at the four times these experiments were performed. On two occasions, neutrophils killed sialylated gonococci to the same degree and at the same rate as control (nonsialylated) gonococci, and on two other occasions, sialylated gonococci were killed to the same degree but at a slightly slower rate than were control gonococci (Fig. 6) . Thus, when these sets of data are combined for presentation in Fig. 6 , the standard deviations seen at 45 min are rather large, whereas they are much smaller for the data presented at 90 and 135 min.
We interpreted the results of our phagocytic-killing assays to indicate that neutrophil-endogenous sialidase, or perhaps other glycosidases, slowly removed sialic acid from gonococcal LOS, allowing gonococci to adhere and be subsequently killed over the relatively long (135-min) assay. Alternatively, sialylated LOS was gradually turned over on the gonococcal surface, allowing nonsialylated LOS to dilute out the sialylated LOS. Thus, whereas growth in GC broth in the presence of 50 ,ug of CMP-NANA per ml is sufficient to sialylate gonococci and prevent their nonopsonic adherence to neutrophils, it appears that long-term (2-to 3-h) incubation of gonococci with neutrophils in vitro results in loss of sialylation.
To address this question, we performed adherence assays for 90 min, instead of the standard 20 50 ,ug of CMP-NANA per ml gradually regained the ability to adhere to neutrophils over the 90-min adherence assay (Fig.  7) . The presence of 50 jig of CMP-NANA per ml in these assays slightly slowed the increased adherence over time, suggesting that there was a small degree of sialic acid incorporation in the presence of CMP-NANA in buffer (PBSG).
Opsonization do not adhere to, and are not phagocytically killed by, human neutrophils in the absence of serum (47) . However, when opsonized with fresh normal human serum, Opagonococci are phagocytically killed by human neutrophils to the same degree as are nonopsonized Opa+ gonococci (13, 45, 59) . To see whether sialylation of gonococci affects their ability to be opsonized, we grew Opa-gonococci in the presence or absence of 50 ,ug of CMP-NANA per ml, opsonized them with 5% fresh normal human serum in PBSG for 30 min at 37°C, and measured their ability to adhere to neutrophils as described in Materials and Methods. Growth in CMP-NANA decreased the ability of gonococci to be opsonized by fresh human serum by about 30% compared with that of gonococci grown without CMP-NANA. The mean number of gonococci per neutrophil (+ the standard deviation) without CMP-NANA or serum was 0.45 + 0.28 (n = 4), that without CMP-NANA but with serum was 9.45 + 1.54 (n = 4), that with CMP-NANA without serum was 0.28 + 0.30 (n = 2), and that with CMP-NANA and serum was 6.45 + 0.63 (n = 4). This was substantially less inhibition than that seen for nonopsonic adherence. Whether such a limited effect on opsonization is biologically relevant in regard to gonococcal infection remains to be determined.
DISCUSSION
We showed that Opa4 gonococci grown in the presence of increasing concentrations of CMP-NANA (up to 50 ,ug/ml) adhered to neutrophils in the absence of serum significantly less than did Opa4 gonococci grown without CMP-NANA. On the other hand, growth in CMP-NANA did not lead to a significant decrease in the ability of Opa-gonococci to be opsonized by fresh normal human serum. All of the effects we observed appeared to be due to sialylation of LOS, since (i) SDS-PAGE LOS profiles changed after growth in CMP-NANA, consistent with the addition of sialic acid; (ii) sialidase treatment of CMP-NANA-grown gonococci reversed all effects; and (iii) a stable LOS variant that was not sialylated when grown in the presence of up to 50 ,g of CMP-NANA per ml adhered to the same degree as gonococci grown without CMP-NANA. The mechanisms by which sialylation of LOS affects the functions of Opa proteins remain to be elucidated.
It is interesting that there is a dichotomy between the effects of CMP-NANA on gonococcal interactions with host humoral and cellular defenses. On the one hand, Opa4 gonococci grown in the presence of 50 ,g of CMP-NANA per ml had a dramatically decreased association with neutrophils and were totally resistant to the bactericidal action of serum. On the other hand, CMP-NANA had only minimal effects on the ability of Opa-gonococci to be opsonized by the serum towards which they were resistant. Thus, whereas sialylated gonococci resist the bactericidal activity of normal human serum (by avoiding recognition by antibody [37] , or perhaps by other mechanisms), they do have the capacity to be coated with opsonic complement. The various mechanisms behind these observations remain to be investigated.
Most isolates from gonorrhea urethral exudates contain more opaque or Opa+ gonococci than Opa-gonococci (20, 47, 53 (1, 28) . Our observations in this report indicate that such intracellular sialylated gonococci must be opsonized prior to their ingestion; if they were not, they would not be able to associate with neutrophils. These combined observations also suggest that the concentration of complement components in the urethra is by definition functional and sufficient for opsonization.
In regard to the opsonization experiments, it can be questioned whether 5% fresh human serum is optimal for opsonization. Such a relatively low concentration of serum was used because F62 gonococci (grown without CMP-NANA) are very serum sensitive. Previous studies in our laboratory showed that 5% serum is an optimal compromise at which significant opsonization occurs in the absence of serum killing (45) . Such opsonization and killing are complement dependent, since serum heated at 56°C for 30 min neither kills nor opsonizes Opa-F62 gonococci (45) .
In the adherence studies, but not in the phagocytic-killing or LDCL studies, we used neutrophils stimulated with the chemotactic peptide formylmethionylleucylphenylalanine. Farrell and Rest showed that human peripheral blood neutrophils bind substantially more Opa+ gonococci after incubation with any of a number of potent neutrophil-stimulating agents, including formylmethionylleucylphenylalanine, the calcium ionophore A23187, and the cocarcinogen phorbol myristate acetate (11) . We concluded from these observations that (unidentified) Opa receptors are located within the membranes of specific granules and brought to the cytoplas- (Fig. 6) , in which gonococci grown with CMP-NANA were killed to the same degree as controls, albeit somewhat slower, and by the adherence assays over time (Fig. 7) .
A very simple, but very important, observation is that the CMP-NANA effects we observed in our studies were dose dependent. Thus, sialylation of gonococcal LOS is not an all-or-nothing phenomenon. Even in our in vitro assays, the longer sialylated gonococci were incubated without CMP-NANA, the more the effects of CMP-NANA diminished. We assume that the 50-p,g/ml CMP-NANA that we used to confer maximal sialylation, and maximally inhibit biological functions, was much higher than the amounts of sialic acid actually found in gonorrhea pus (which are not known). 
